List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1143 studies with search of: China
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
2 Completed Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Conditions: Breast Cancer;   Metastases
Interventions: Drug: Ixabepilone + Capecitabine;   Drug: Capecitabine
3 Completed Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections
Condition: Abdominal Abscess
Intervention: Drug: tigecycline
4 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
5 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
6 Recruiting LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Conditions: ErbB2 (HER2) Amplified Gastric;   Esophageal;   or Gastro-Esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.
Intervention: Drug: Lapatinib
7 Active, not recruiting Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Conditions: Osteoarthritis;   Arthritis, Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Diclofenac + Omeprazole
8 Recruiting PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Condition: Non Hodgkin Lymphoma
Interventions: Drug: enzastaurin;   Drug: placebo
9 Active, not recruiting A Study to Assess the Safety and Efficacy of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Biological: Placebo;   Biological: Adalimumab 40 mg;   Biological: Adalimumab 80 mg
10 Recruiting A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.
Condition: Kidney Transplantation
Interventions: Drug: mycophenolate mofetil [CellCept];   Drug: tacrolimus;   Drug: tacrolimus;   Drug: corticosteroids
11 Completed A Local Register Study For Major Depression Of Paroxetine Controlled Release
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: Paroxetine CR;   Drug: Paroxetine IR
12 Recruiting Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
Condition: Inflammatory Breast Cancer
Interventions: Drug: lapatinib (Tykerb);   Drug: pazopanib (GW786034);   Drug: Pazopanib
13 Recruiting A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections
Conditions: Fungemia;   Fungal Infections
Interventions: Drug: micafungin (Mycamine);   Drug: itraconazole
14 Recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
15 Active, not recruiting Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: pemetrexed;   Drug: Placebo
16 Terminated Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Drug: PF-3512676;   Drug: Cisplatin;   Drug: Gemcitabine + Cisplatin
17 Recruiting Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-Cisplatin for Extensive Disease Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: Amrubicin Hydrochloride;   Drug: Etoposide-Cisplatin combined chemotherapy
18 Active, not recruiting Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Dutasteride matched placebo;   Drug: Dutasteride 0.5mg capsule
19 Recruiting Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Indacaterol 150 µg;   Drug: Indacaterol 300 μg;   Drug: Placebo
20 Completed AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine
Condition: Cerebral Infarction
Interventions: Drug: Erigeron breviscapus injection;   Drug: hua tuo zai zao wan (a herbal medicine pill);   Drug: Compound stroke herbal medicine (8 herbal)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services